Home Cart 0 Sign in  
X

[ CAS No. 130929-57-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 130929-57-6
Chemical Structure| 130929-57-6
Chemical Structure| 130929-57-6
Structure of 130929-57-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 130929-57-6 ]

Related Doc. of [ 130929-57-6 ]

Alternatived Products of [ 130929-57-6 ]
Product Citations

Product Details of [ 130929-57-6 ]

CAS No. :130929-57-6 MDL No. :MFCD00866580
Formula : C14H15N3O5 Boiling Point : -
Linear Structure Formula :- InChI Key :JRURYQJSLYLRLN-BJMVGYQFSA-N
M.W : 305.29 Pubchem ID :5281081
Synonyms :
OR-611
Chemical Name :(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide

Calculated chemistry of [ 130929-57-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 6
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 81.09
TPSA : 130.38 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.59
Log Po/w (XLOGP3) : 2.14
Log Po/w (WLOGP) : 1.67
Log Po/w (MLOGP) : -0.13
Log Po/w (SILICOS-IT) : -0.63
Consensus Log Po/w : 0.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.89
Solubility : 0.396 mg/ml ; 0.0013 mol/l
Class : Soluble
Log S (Ali) : -4.51
Solubility : 0.00944 mg/ml ; 0.0000309 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -1.66
Solubility : 6.68 mg/ml ; 0.0219 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 5.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.95

Safety of [ 130929-57-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P273-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335-H413 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 130929-57-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 130929-57-6 ]
  • Downstream synthetic route of [ 130929-57-6 ]

[ 130929-57-6 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 146698-91-1 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
94.1% With pyridine; aluminum (III) chloride In dichloromethane at 0 - 45℃; for 2.5 h; N, N-diethyl-2-cyano-3- (3-methoxy-4-hydroxy-5-nitrophenyl) acrylamide (20g) (0. 062mole) of the formula 4 where, R=methyl obtained by the process described in step (i) of Example-2 is charged with pyridine 50ml along with dichloromethane 120 ml and stirred and cooled to 0-5 degrees and slowly charged the aluminium chloride 32g (0.239 mole) keeping the temperature below 5 and stirred at 0-5 C for 30 minutes. After maintaining for 30 minutes the reaction mixture was slowly raised to room temperature to 40-45 C and stirred for 2 hours. The reaction mixture quenched in dilute hydrochloric acid and ice water (50ml) after removing the methylene chloride and stirred for 60 minutes. The formed product was filtered and dried. The dried weight is 18g (94. 1 percent) with HPLC purity of about 94.42percent. It was purified using methanol and toluene as a solvent to get the ENTACAPONE as a pure product having HPLC purity of 99.5percent. it is matching with in all respect with the product obtained from the Example-1 (step-2).
Reference: [1] Patent: WO2005/63693, 2005, A1, . Location in patent: Page/Page column 9
  • 2
  • [ 1047659-01-7 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
91.1% With hydrogenchloride In water; isopropyl alcohol at 20 - 30℃; A dissolution comprising a mixture of water (1200 <n="14"/>ml) and 35 percent aq. HCl is added to a suspension of the piperidine salt of Entacapone obtained in a) (119 g; 305 mmole) in isopropanol (600 ml), keeping the temperature from 20 to 300C(29.8 ml; 335 mmole). The resulting precipitate is cooled at 0-50C, filtered off and washed with isopropanol/water (80 ml: 160 ml), and finally, with water (240 ml). The resulting product is dried at 400C in a vacuum oven to provide 84.8 g (yield= 91.1 percent) of an orange solid (m.p.= 162.4-163.5°C;HPLC purity= 99.8 percent (Z-isomer= 0.05 percent) ) .
Reference: [1] Patent: WO2008/98960, 2008, A1, . Location in patent: Page/Page column 12-13
  • 3
  • [ 857629-78-8 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: With aluminum (III) chloride; triethylamine In dichloromethane at 0 - 5℃; for 3 - 4 h; Heating / reflux
Stage #2: With hydrogenchloride In dichloromethane at 0 - 20℃; for 0.5 h;
A round-bottom flask under nitrogen atmosphere is loaded with N,N-diethyl-2-cyano-3-(-3-methoxy-4-hydroxy-5-nitrophenyl-)-acrylamide (134 g, 0.421 mol) dissolved in dichloromethane (0.65 l) and triethylamine (128 g, 1.26 mol). The solution is cooled to 0-5° C. and aluminium trichloride (67.4 g, 0.505 mol) is added in portions. After that, the mixture is refluxed for 3-4 hours, until completion of the conversion. The reaction mixture is cooled to 0-5° C., a 20percent hydrochloric acid solution (0.5 l) is dropped in the mixture, which is left under stirring at room temperature for 30 minutes. The resulting solid is filtered, washing with water (0.1 l.x.3), and dried in a static dryer under reduced pressure at 50° C.; 126 g are obtained. Yield: 98percent.1H-NMR (300 MHz), δ (DMS0) 7.90 (d, 1H); 7.75 (d, 1H); 7.60 (s, 1H); 3.40 (m, 4H); 1.15 (m, 6H).
98% With aluminum (III) chloride; triethylamine In dichloromethane Example 2
Preparation of N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-acrylamide (entacapone); (I)
A round-bottom flask under nitrogen atmosphere is loaded with N,N-diethyl-2-cyano-3-(-3-methoxy-4-hydroxy-5-nitrophenyl-)-acrylamide (134 g, 0.421 mol) dissolved in dichloromethane (0.65 1) and triethylamine (128 g, 1.26 mol).
The solution is cooled to 0-5°C and aluminium trichloride (67.4 g, 0.505 mol) is added in portions.
After that, the mixture is refluxed for 3-4 hours, until completion of the conversion.
The reaction mixture is cooled to 0-5°C, a 20percent hydrochloric acid solution (0.5 1) is dropped in the mixture, which is left under stirring at room temperature for 30 minutes.
The resulting solid is filtered, washing with water (0.1 I x 3), and dried in a static dryer under reduced pressure at 50°C; 126 g are obtained. Yield: 98percent.
1H-NMR (300 MHz), δ (DMSO): 7.90 (d, 1 H); 7.75 (d, 1 H); 7.60 (s, 1 H); 3.40 (m, 4H); 1.15 (m, 6H).
92%
Stage #1: With aluminum (III) chloride; triethylamine In tetrahydrofuran at 0℃; Reflux
Stage #2: With hydrogenchloride In tetrahydrofuran; water for 6 h; Cooling
(E)-N,N-diethyl-2-cyano-3-(3-methoxy-4-hydroxy-5- nitrophenyl)acrylamide (32 g) and tetrahydrofuran (250 mL) were added to a 500 mL flask at room temperature to form a reaction mixture. The mixture was cooled toO °C. After anhydrous aluminum chloride (16.0 g) was added to the reaction mixture, triethylamine (41.6 mL) was added dropwise to the reaction mixture. The reaction mixture was heated under reflux and then cooled. The cooled mixture was dropwise added to dilute hydrochloric acid (10percent) followed by adding 314 mL of water. It was allowed to maintain at the same temperature for 6 hours for crystallization and was centrifuged and dried to obtain 28.0 g of (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy- 5-nitrophenyl) acrylamide (entacapone). The yield was 92percent. The HPLC purity of the E-isomer was 99.92percent.
76%
Stage #1: With aluminum (III) chloride In N,N-dimethyl-formamide at 5 - 80℃; for 16 h;
Stage #2: With hydrogenchloride; water In N,N-dimethyl-formamide at 5 - 30℃; for 2 h;
Method B; AlCl3 (1.25 eq) was added portionwise to a solution of E-2-cyano-3-(3-methoxy-4-hydroxy-5-nitrophenyl)-N,N-diethylacrylamide (1.0 eq) in N,N-dimethylformamide (8.6 mL/g) at 5 °C under a nitrogen atmosphere. The mixture was heated to 80 °C and stirred for 16 h. The resulting red solution was cooled to 10 °C and 35percent aqueous HCl solution (5 eq) was added, followed by addition of H2O (10 mL/g) at 30 °C. The suspension was stirred at 5 °C for 2 h. The solid was filtered off, washed with cold water and dried under reduced pressure to give E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide.
61%
Stage #1: With pyridine; aluminum (III) chloride In N,N-dimethyl-formamide at 5 - 90℃; for 15 h;
Stage #2: With hydrogenchloride; water In N,N-dimethyl-formamide at 5 - 30℃; for 1 - 3 h;
Method A; AlCl3 (1.25 eq) and pyridine (3.0 eq) were added to a solution of E-2-cyano-3-(3-methoxy-4-hydroxy-5-nitrophenyl)-N,N-diethylacrylamide (1.0 eq) in N,N-dimethylformamide (8.6 mL/g) at 5 °C under a nitrogen atmosphere. The mixture was heated to 80 °C- 90 °C and stirred for 15 h. The resulting red solution was cooled to 10-30 °C and 35percent aqueous HCI solution (5 eq) and H2O (10 mL/g) were added. Stirring was continued for 1-3 h at 5 °C and the precipitated solid was collected by filtration, washed with cold water and dried under reduced pressure to give E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide.
56.1% With pyridine; aluminum (III) chloride In chloroform at 0 - 5℃; Heating / reflux (iii) Preparation of N1,N1-diethyl-(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-2-propenamide (entacapone); A reactor vessel is charged with dry chloroform (30 L), N1,N1-diethyl-(E)-2-cyano-3-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-propenamide (1.083 kg, 3.392 mol) and aluminium chloride (0.498 kg, 3.731 mol). The suspension is agitated and cooled down to 0-5° C. Dry pyridine (1.180 kg, 14.923 mol), dissolved in dry chloroform (3 L) is transferred to a dropping funnel and added carefully, drop wise to the suspension. After complete addition, the reaction mixture is agitated and heated to reflux until an in process control indicates the ether cleavage to be complete. Most of the chloroform is distilled out of the reaction mixture. Water (7 L) is added and the residual chloroform is removed out of the two phase mixture by aceotropic distillation. The distilled water is transferred back to the reactor together with ethylacetate (25 L). The mixture is cooled down to 0-5° C. and 25percent HCl (20 L) is added. The two phase mixture is agitated at ambient temperature for 30 minutes. After phase separation the watery layer is extracted twice with ethylacetate (2.x.12 L). The combined organic layers are distilled down to a final volume of 5 L. The product is precipitated by the addition of hexanes (10 L). After agitating for 1 hour the resulting solid is collected on a 20 L Buchner funnel by vacuum filtration. The filtercake is washed with water, transferred to trays and dried in a vacuum oven at 30° C. under reduced pressure, to gain the pure product as a green solid (0.581 kg, 56.1percent)Mp.: 161.05° C. HPLC: 99.37percent E-Entacapone+0.19percent Z-Entacapone. API/MS: [M+H]+ 306.17, [M+H]+-H2O=288.11, [M+H]+-Et=278.17, [M+H]+-NEt2=233.
0.9 g With pyridine; aluminum (III) chloride In dichloromethane at 0 - 45℃; (E)-2-Cyano-N,N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)acrylamide 10(1.0 g, 0.0031 mol) was added to a solution of dichloromethane (6.0 ml) and pyridine(2.5 ml) at 0–5 °C. Aluminium chloride (1.58 g, 0.0118 mol) was added at 0–5 °C overa period of 15–20 min and maintained for 30 min. Reaction mass temperature wasraised to RT and maintained for 2–3 h at 40–45 °C. After completion of the reaction,the reaction mass was quenched into dilute hydrochloric acid and ice water (3.0 ml).The organic layer was separated and the solvent distilled off to get the pure entacapone1 (0.9 g).1H NMR (400 MHz, CDCl3): δ 1.30 (s, 1H), 3.50 (s, 4H), 6.22 (s, 1H), 7.57 (s,1H), 7.88 (s, 1H), 8.12 (s, 1H), 10.93 (s, 1H). 13 C NMR (100 MHz, CDCl3): δ 12.53,13.55, 40.87, 43.32, 107.92, 115.33, 118.44,120.73, 124.41, 133.44, 145.19, 147.09,148.17, 162.59; MS (ESI) m/z: 304.5 [M-1].

Reference: [1] Patent: US2008/146829, 2008, A1, . Location in patent: Page/Page column 4
[2] Patent: EP1935873, 2008, A1, . Location in patent: Page/Page column 6
[3] Patent: WO2013/149566, 2013, A1, . Location in patent: Paragraph 0044
[4] Patent: EP1978014, 2008, A1, . Location in patent: Page/Page column 11
[5] Patent: EP1978014, 2008, A1, . Location in patent: Page/Page column 11
[6] Patent: US2008/103191, 2008, A1, . Location in patent: Page/Page column 17
[7] Patent: WO2006/64296, 2006, A1, . Location in patent: Page/Page column 7-8
[8] Patent: WO2006/64296, 2006, A1, . Location in patent: Page/Page column 8
[9] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
[10] Synthetic Communications, 2014, vol. 44, # 9, p. 1274 - 1278
  • 4
  • [ 26391-06-0 ]
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With piperidine In 1,2-dimethoxyethane; n-heptane for 15 - 25 h; Heating / reflux
Stage #2: at 25 - 35℃; for 24 h;
Example- 1:Preparation of (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide (Entacapone).3,4-Dihydroxy-5-nitrobenzaldehyde (50 g), N,N-diethyl cyanoacetamide (76.5 g), piperidine (19.2 g), are charged to a reaction vessel containing a mixture of dimethoxy ethane (200 ml) and heptane (200 ml). The reaction mixture is refluxed for 15-25 hours till the starting material is <n="7"/>disappeared (monitored by HPLC). The solvent was removed by distillation under high vacuum at 70-80°C. Then cooled to 25-35°C. To the crude mass in the flask was added methylene chloride (1.0 lit) at 25°C-35°C. The mixture was stirred for 24 hours at that temperature. It is then filtered and dried and charged to reaction flask containing methanol. The mixture is charcolised, filtered and concentrated to give title compound in 75percent yield (HPLC 99.78percent, Z- isomer content <0.1percent).
75.5% With piperidine In isopropyl alcohol for 12 - 15 h; Heating / reflux Example 1
Crystallographically pure (E)-N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide Form C
3,4-Dihydroxy-5-nitrobenzaldehyde (10.0 gm, 54.6 mmol), N,N-diethyl-cyanoacetamide (15.5 gm, 11.06 mmol) and piperidine (15.0 gm, 170.3 mmol) is charged to isopropanol (200 ml).
The reaction mixture is heated at reflux for 12 to 15 hours until the starting material is disappeared.
After the reaction is complete, the reaction mixture is cooled to room temperature and acetic acid glacial (15 ml) is added.
The reaction mixture is concentrated, followed by dilution with ethyl alcohol (50 ml).
The mixture is stirred overnight and filtered.
The isolated product is dried under vacuum to provide crystallographically pure Form C of crystalline (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide with melting point of 156-160° C.
The title product is obtained as a crystalline solid in 75.5percent yield. HPLC Purity=99.45percent (Z-isomer 0.24percent).
Mass Spectra=m+1 306.1 (100percent).
59.63%
Stage #1: With piperidine; acetic acid In ethanol for 6 h; Heating / reflux
Stage #2: at 65℃; for 0.5 h;
Example 1; A mixture of 3,4-dihydroxy-5-nitro benzaldehyde (50Og), N,N-diethyl cyano acetamide(575ml), acetic acid (375ml) and piperidine (500ml) in ethanol (4.51) were refluxed for 6 hrs. Ethanol was distilled off under vacuum and 1.5 1 of formic acid was added to the residue at65° C and stirred for 30 mins at 65° C. The reaction mixture was cooled to R T and charged with methylene dichloride. The organic layer was separated and washed twice with 2 x 3.5 1 water. Methylene dichloride was distilled off under vacuum from the organic layer and the residue was treated with ethyl acetate 1.25 1. The yellow solid was filtered out from the solvent, washed with 1.25 1 ethyl acetate and dried in an electric oven at 60-70° C to obtain crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitro phenyl) acrylamide.Yield of crude entacapone 495g (59.63 percent), Purity 99.2++Z- isomer 0.5percent
13% With 1-methyl-piperazine In methanol at 20℃; for 20 h; General procedure: A solution of arylaldehyde (1 equiv), 2-cyanoacetamide or derivative (1.0-1.5 equiv) and N-methylpiperazine (0.05-1.05 equiv) in methanol (2-10 ml) was stirred at room temperature overnight. After addition of an equivalent volume of water/methanol (1:1) or 1 N HCl/methanol (1:1) for acidic products, the precipitate was collected by filtration and washed with water/methanol (1:1). If precipitation did not occur, the mixture was evaporated and the residue was purified by flash chromatography.
99.80 % de
Stage #1: With piperidine In cyclohexane; toluene at 20 - 94℃;
Stage #2: With acetic acid In cyclohexane; toluene at 25 - 30℃;
Example 3; Preparation of Entacapone; 3,4-dihydroxy 5-nitrobenzaldehyde (17 gm) and diethylcyanoacetamide (16.9 gm) was charged in a solution of toluene (85 ml) and cyclohexane (85 ml ml) at rt followed by addition of piperidine (0.78 gm). The reaction temperature was raised to reflux (88-94° C.) and removed water azeotrophically from the reaction. After completion of reaction glacial acetic acid (34 ml) was added to reaction mixture followed by cooling at 25° C. to 30° C. The reaction mixture was stirred and filtered. The residue was washed with toluene and water. The residue was dried under vacuum at 50-55° C. to get Entacapone (22.7 gm).HPLC Purity: E-isomer 99.42percent and Z isomer content 0.10percent.
2.1 g
Stage #1: at 108 - 112℃; Dean-Stark
Stage #2: at 90 - 95℃; for 1 h;
A round bottomed flask equipped with a stirrer, thermowell, and a dean-Stark condenser was charged with 1.83 g of 3,4-dihydroxy-5-nitrobenzaldehyde, 1.54 g of N,N-diethyl-2-cyano acetamide, 150 mg of IRA 120 resin, and 15 mL of toluene. The mixture was refiuxed at 108 - 112 °C and the formed water was removed azeotropically until the starting material was consumed (approximately 12-16 hours). The resin was removed by filtration and the reaction mass was concentrated by distilling the solvent completely under vacuum. A mixture of geometric isomers was formed with the ratio of E/Z isomers being approximately 70:30. The concentrated mass was treated with a solution of 1percent HBr in acetic acid and maintained under stirring at 90-95 °C for 1 hour. The reaction mixture was cooled to room temperature and stirred for 20-24 hours. The reaction mixture was filtered and the precipitate recrystallized from alcohol to afford 2.1 g of Pure (E)-entacapone. The melting point of the resulting compound was 163.3 - 164.9 °C.

Reference: [1] Patent: WO2007/77572, 2007, A1, . Location in patent: Page/Page column 5-6
[2] Patent: US2008/4343, 2008, A1, . Location in patent: Page/Page column 5
[3] Patent: WO2005/63695, 2005, A1, . Location in patent: Page/Page column 11
[4] Patent: WO2007/54950, 2007, A1, . Location in patent: Example 1
[5] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
[6] Patent: WO2005/70881, 2005, A1, . Location in patent: Page/Page column 7
[7] Patent: WO2007/77572, 2007, A1, . Location in patent: Page/Page column 6
[8] Patent: WO2008/23380, 2008, A1, . Location in patent: Page/Page column 7-8
[9] Patent: WO2008/23380, 2008, A1, . Location in patent: Page/Page column 8
[10] Patent: WO2008/53304, 2008, A2, . Location in patent: Page/Page column 5
[11] Patent: US2010/234632, 2010, A1, . Location in patent: Page/Page column 4
[12] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
[13] Patent: WO2014/164667, 2014, A1, . Location in patent: Page/Page column 29-30
  • 5
  • [ 26391-06-0 ]
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
  • [ 145195-63-7 ]
YieldReaction ConditionsOperation in experiment
75.5%
Stage #1: With piperidine In isopropyl alcohol for 12 - 15 h; Heating / reflux
Stage #2: With acetic acid In isopropyl alcohol at 20℃;
EXAMPLE 1;
Crystallographically pure (E)-N, N-Diethyl-2-cyano-3-(3, 4dihydroxy-5-nitrophenyl)- acrylamide Form C; 3,4-Dihydroxy-5-nitrobenzaldehyde (10.0 gm), N, N-Diethylcyanoacetamide (15.5 gm) and piperidine (15.0 gm) is charged to isopropanol (200 ml). The reaction mixture is refluxed for 12 to 15 hours till the starting material is disappeared. The solution is slowly cooled to room temperature and acetic acid glacial (15 ml) is added to it thereafter reaction mixture is concentrated followed by dilution with ethyl alcohol (50 ml). The mixture is stirred overnight and filtered. Isolated product thus obtained is dried under vacuum to afford crystallographically pure Form C of crystalline (E)-N, N-Diethyl-2-cyano-3- (3, 4-dihydroxy- 5-nitrophenyl) acrylamide with melting point between 156-160 °C. The title product is obtained as crystalline solid in 75.5 percent yield. HPLC Purity = 99.45percent (Z-isomer 0.24percent). Mass Spectra = m+1 306.1 (100percent).
41.99 % de
Stage #1: at 75 - 80℃;
Stage #2: With ammonium acetate In ethanol for 24 h;
1: Preparation of racemic 2-cvano-3-(3,4-dihvdroxy-5-nitrophenyl)-N,N-diethylprop-2~ en amide3,4-dihydroxy-5-nitro-benzaldehyde (5Og) and N,N-diethyl-2-cyano acetamide (99.4g) were taken together in dry ethanol (100OmL) and refluxed at 75-8O0C for 15-20min. followed by the addition of ammonium acetate (27g) lot-wise over a period of 24hrs at every 2 hours of interval. After completion of reaction the content was cooled to room temperature and the ethanol was distilled off under vacuum. The residue was taken in dichloromethane (100OmL) and stirred for 15min at 25-300C followed by the addition of purified water (100OmL) and stirred at 25-3O0C for 1 hr. The layer if not cleared was filtered through hyflobed and washed with methylene chloride. The organic layer was separated and the aqueous layer was washed with dichloromethane twice. The organic layer were combined and treated with dilute hydrochloric acid 30OmL (1:1 ratio of HCl and water). The organic layer was separated and treated with purified water to remove any undissolved impurities, the water treatment was repeated two to three times and further the organic layer was treated with activated carbon at 25-30 ° C and filtered. The filtrate distilled off under vacuum at 600C and the residue was taken in ethyl alcohol at 25-3O0C, stirred for 15- 20min. and distilled off under vacuum at 350C. To the residue was added purified water and the <n="9"/>stirred for 2 hrs at 25-300C3 filtered and washed with water and dried to obtain racemic 2-cyano- 3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide.(Dry Weight : 6Og (72.20percent), HPLC purity : 98.32percent, E isomer (69.80percent) and Z isomer (28.52percent)
40 % de With IRA 120 resin In toluene at 108 - 112℃; Dean-Stark A round bottomed flask equipped with a stirrer, thermowell, and a dean-Stark condenser was charged with 1.83 g of 3,4-dihydroxy-5-nitrobenzaldehyde, 1.54 g of N,N-diethyl-2-cyano acetamide, 150 mg of IRA 120 resin, and 15 mL of toluene. The mixture was refiuxed at 108 - 112 °C and the formed water was removed azeotropically until the starting material was consumed (approximately 12-16 hours). The resin was removed by filtration and the reaction mass was concentrated by distilling the solvent completely under vacuum. A mixture of geometric isomers was formed with the ratio of E/Z isomers being approximately 70:30. The concentrated mass was treated with a solution of 1percent HBr in acetic acid and maintained under stirring at 90-95 °C for 1 hour. The reaction mixture was cooled to room temperature and stirred for 20-24 hours. The reaction mixture was filtered and the precipitate recrystallized from alcohol to afford 2.1 g of Pure (E)-entacapone. The melting point of the resulting compound was 163.3 - 164.9 °C.
Reference: [1] Patent: WO2005/66117, 2005, A1, . Location in patent: Page/Page column 11
[2] Patent: WO2007/90923, 2007, A1, . Location in patent: Page/Page column 9-11
[3] Patent: WO2007/90923, 2007, A1, . Location in patent: Page/Page column 11-12
[4] Patent: WO2008/7093, 2008, A1, . Location in patent: Page/Page column 9
[5] Patent: WO2009/84031, 2009, A2, . Location in patent: Page/Page column 7-8
[6] Patent: WO2014/164667, 2014, A1, . Location in patent: Page/Page column 29-30
  • 6
  • [ 1067233-93-5 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With aluminum (III) chloride In N,N-dimethyl-formamide at 5 - 80℃; for 15 h;
Stage #2: With hydrogenchloride; water In N,N-dimethyl-formamide at 5 - 30℃; for 2.5 h;
Example 10: Preparation of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide using AlCl3 (compound of formula (I)); AlCl3 (75.0 g, 0.56 mol) was added portionwise to a solution of E-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylacrylamide (150.0 g, 0.45 mmol) in N,N-dimethylformamide (1290 mL) at 5 °C under a nitrogen atmosphere. The mixture was heated to 80 °C and stirred for 15 h. The resulting red solution was cooled to 10 °C and 35percent aqueous HCl solution (200 mL) was added, followed by the slow addition of H2O (1500 mL) at 30 °C. The suspension was stirred at 5 °C for 2.5 h. The solid was filtered off, washed with cold water and dried under reduced pressure to give 126.3 g (92percent yield) of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide. Light yellow solid. 1H-RMN (400 MHz, CDCl3) δ 7.92 (1 H, d, J = 2.2), 7.73 (1 H, d, J = 2.2), 7.62 (1 H, s), 3.40 (4H, broad q), 1.14 (6H, broad t). Purity by HPLC: 99.7percent, (Z)-isomer: 0.2percent.
80%
Stage #1: With pyridine; aluminum (III) chloride In N,N-dimethyl-formamide at 5 - 80℃; for 15 h;
Stage #2: With hydrogenchloride; water In N,N-dimethyl-formamide at 5 - 30℃; for 2 h;
Example 9: Preparation of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide using AlCl3 / pyridine (compound of formula (I)); AlCl3 (371 mg, 2.78 mmol) and pyridine (0.54 mL, 6.69 mmol) were added portionwise to a solution of E-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylacrylamide (742 mg, 2.23 mmol) in N,N-dimethylformamide (6.4 mL) at 5 °C under a nitrogen atmosphere. The mixture was heated to 80 °C and stirred for 15 h. The resulting red solution was cooled to 10 °C and 35percent aqueous HCl solution (1.0 mL) was added, followed by the addition of H2O (7.4 mL) at 30 °C. Stirring was continued for 2 h at 5 °C and the precipitated solid was collected by filtration, washed with cold water and dried under reduced pressure to give 541 mg (80percent yield) of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide. HPLC purity: 96.0percent, (Z)-isomer: 0.4percent.
74%
Stage #1: With boron tribromide In dichloromethane at -15 - 20℃;
Stage #2: With water In dichloromethane for 0.5 h;
Example 8: Preparation of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide using BBr3 (compound of formula (I)); A 1.0 M solution of BBr3 in CH2Cl2(1.62 ml, 1.62 mmol) was added dropwise to a solution of E-2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylacrylamide (154 mg, 0.46 mmol) in CH2Cl2 (0.5 mL) at -15 °C under a nitrogen atmosphere. The resulting red suspension was stirred for 1 h at -15 °C and allowed to warm to room temperature overnight. The reaction was quenched by the addition of H2O (4 mL) and stirred for 30 min. The aqueous phase was extracted with EtOAc (3 x 30 mL). The organic layers were combined, washed with saturated brine (20 mL) and dried (Na2SO4). The solvent was eliminated under reduced pressure to give 105 mg (74percent yield) of E-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide.
Reference: [1] Patent: EP1978014, 2008, A1, . Location in patent: Page/Page column 6; 10-11
[2] Patent: EP1978014, 2008, A1, . Location in patent: Page/Page column 6; 10; 11
[3] Patent: EP1978014, 2008, A1, . Location in patent: Page/Page column 6; 10
[4] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 7
  • [ 145195-63-7 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
14% With hydrogenchloride In water; toluene at 7 - 20℃; for 4 h; Heating / reflux Mother liquors, containing mainly isomer (Z), were concentrated under vacuum, treated with 100ml of toluene and a catalytic amount of hydrochloric acid (2ml), and stirred under reflux for 4 hours, with the aim of conversion of isomer (Z) ((Z)-2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N,N-diethyl-2-propenamide) into isomer (E) (Entacapone). After cooling down to room temperature, 50ml 4.5percent HCl was added dropwise and the obtained suspension was stirred at 7-100C for 1 hour. A second batch of crude 2-cyano-3-(3,4-dihydroxy-5- nitrophenyl)-N,N-diethyl-2-propenamide (a mixture of (E) and (Z) isomers) was filtered off, washed with 2x10ml toluene and dried at 400C. Crystallization from methanol gave 2.4g (14percent) of pure Entacapone as polymorph form A.
Reference: [1] Patent: WO2008/7093, 2008, A1, . Location in patent: Page/Page column 9
  • 8
  • [ 146698-91-1 ]
  • [ 130929-57-6 ]
  • [ 145195-63-7 ]
Reference: [1] Patent: WO2007/94007, 2007, A1, . Location in patent: Page/Page column 15
  • 9
  • [ 686349-59-7 ]
  • [ 130929-57-6 ]
Reference: [1] Patent: US2006/258877, 2006, A1, . Location in patent: Page/Page column 4
[2] Patent: WO2007/94007, 2007, A1, . Location in patent: Page/Page column 15-16
[3] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 10
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
Reference: [1] Patent: US4963590, 1990, A,
  • 11
  • [ 1291066-63-1 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 12
  • [ 121-33-5 ]
  • [ 130929-57-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
[2] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
[3] Patent: WO2013/149566, 2013, A1,
  • 13
  • [ 6635-20-7 ]
  • [ 130929-57-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
[2] Patent: CN108440340, 2018, A,
[3] Patent: CN108440340, 2018, A,
  • 14
  • [ 345317-61-5 ]
  • [ 130929-57-6 ]
Reference: [1] Journal of Pharmacy and Pharmacology, 2001, vol. 53, # 11, p. 1489 - 1498
  • 15
  • [ 404860-98-6 ]
  • [ 130929-57-6 ]
Reference: [1] Journal of Pharmacy and Pharmacology, 2001, vol. 53, # 11, p. 1489 - 1498
  • 16
  • [ 26391-06-0 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
[2] Patent: WO2013/149566, 2013, A1,
  • 17
  • [ 80547-69-9 ]
  • [ 130929-57-6 ]
Reference: [1] Journal of Chemical Sciences, 2015, vol. 127, # 11, p. 1977 - 1991
  • 18
  • [ 134610-30-3 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 19
  • [ 160391-70-8 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 20
  • [ 893419-47-1 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 21
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 22
  • [ 91004-48-7 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
  • 23
  • [ 203861-62-5 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 9, p. 1274 - 1278
  • 24
  • [ 53793-77-4 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 9, p. 1274 - 1278
  • 25
  • [ 6635-20-7 ]
  • [ 26391-06-0 ]
  • [ 130929-57-6 ]
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 11, p. 1427 - 1431
  • 26
  • [ 404860-97-5 ]
  • [ 130929-57-6 ]
Reference: [1] Journal of Pharmacy and Pharmacology, 2001, vol. 53, # 11, p. 1489 - 1498
Recommend Products
Same Skeleton Products
Historical Records
; ;